<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
--------------
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15 (d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event
reported): June 27, 2000
-------------
United Therapeutics Corporation
--------------------------------------------------
(Exact Name of Registrant as Specified in Charter)
Delaware 000-26301 52-1984749
-------- --------- ----------
(State or Other (Commission (I.R.S. Employer
Jurisdiction of File Number) Identification Number)
Incorporation)
1110 Spring Street
Silver Spring, MD 20910
---------------------------------------- ----------
(Address of Principal Executive Offices) (Zip Code)
Registrant's telephone number, including area code:
(301) 608-9292
--------------
<PAGE> 2
ITEM 5. OTHER EVENTS.
On June 27, 2000, the Registrant issued a press release, a copy of which
is attached hereto and incorporated herein by this reference.
ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS
(a) Not applicable.
(b) Not applicable.
(c) Exhibits
Exhibit No. Description
----------- -----------
99.1 Registrant's press release dated June 27, 2000
<PAGE> 3
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
United Therapeutics Corporation
(Registrant)
Date: June 28, 2000 By: /s/ Martine A. Rothblatt
---------------------------------
Name: Martine A. Rothblatt
Title: Chairman and CEO
<PAGE> 4
EXHIBIT INDEX
Exhibit No. Description
----------- -----------
99.1 Registrant's press release dated June 27, 2000
